Project Grant HT94252311022
Award Date 9/30/23
Completion Date 9/29/27
Dollars Obligated $938K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- This $487,623 federal Project Grant, awarded on September 30, 2023 by the Defense Health Agency (DHA) under the Military Medical Research and Development CFDA program (12.420), supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The award recipient is the Trustees of Indiana University, doing business as Indiana University, a major public research university with extensive expertise in biomedical sciences research. The project aims to advance...
- Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $7,195,717.00 to the Trustees of Indiana University for a research project titled "INTRA-ARTICULAR INJECTION OF AMOBARBITAL TO PREVENT POSTTRAUMATIC OSTEOARTHRITIS IN PATIENTS SUSTAINING SEVERE ANKLE TRAUMA." The award has an initial performance period from August 15, 2025 to August 14, 2030. The research aims to investigate the use of...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...
- The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
- This federal Project Grant award of $749,378.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research by the Trustees of Indiana University, doing business as Indiana University, to investigate the systemic administration of STO-609 to prevent post-traumatic osteoarthritis in a translational porcine intraarticular fracture model. The project will run from August 1, 2025 to July 31, 2028. Indiana University, a prominent public...
- Trustees of Indiana University was awarded a $7.8 million project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop pharmacotherapies for the treatment of hydrocephalus and associated conditions from September 1, 2023 through August 31, 2027. Under this award, Indiana University will leverage its expertise in biomedical research to investigate medical solutions targeted toward the military health system....
- The Defense Health Agency awarded a $1,489,868 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 30, 2025 to September 29, 2029, will support the "OVARIAN CANCER ACADEMY: ADVANCING OVARIAN CANCER RESEARCH THROUGH MENTORSHIP, NETWORKING, AND COLLABORATIONS" initiative. The project aims to transform healthcare for military...
- This federal Project Grant award of $158,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a genetically engineered mouse model of spinal ependymoma precursors in NF2-related schwannomatosis. The project will be conducted by the Trustees of Indiana University, a prominent public research university, over a performance period from September 15, 2025 to August 14, 2027. The award aims to advance biomedical research...
- This Project Grant award, with a total funding of $158,500.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports an investigation into redox signaling as a potential therapeutic target for malignant peripheral nerve sheath tumors (MPNST). The ultimate period of performance for this grant is from July 1, 2024 to June 30, 2026. The grant recipient is the Trustees of Indiana University, doing business as Indiana...